These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10360589)

  • 1. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.
    Albella B; Segovia JC; Guenechea G; Pragnell IB; Bueren JA
    Transplantation; 1999 May; 67(10):1348-57. PubMed ID: 10360589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors.
    Tourino C; Pflumio F; Novault S; Massé A; Guiller M; Bonnet ML; Valteau-Couanet D; Hartmann O; Vainchenker W; Beaujean F; Coulombel L; Turhan AG
    Hematol J; 2001; 2(2):108-16. PubMed ID: 11424003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
    Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M
    Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts.
    Peters SO; Kittler EL; Ramshaw HS; Quesenberry PJ
    Blood; 1996 Jan; 87(1):30-7. PubMed ID: 8547656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
    Du Z; Jin H; Cai H; Yang S; Tan WS
    Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F; Bernard A; Bueren JA
    Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
    Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
    Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells.
    Xu R; Reems JA
    Transfusion; 2001 Feb; 41(2):213-8. PubMed ID: 11239225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
    Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
    Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells.
    Denning-Kendall PA; Evely R; Singha S; Chapman M; Bradley BA; Hows JM
    Br J Haematol; 2002 Jan; 116(1):218-28. PubMed ID: 11841420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells.
    Sitnicka E; Buza-Vidas N; Larsson S; Nygren JM; Liuba K; Jacobsen SE
    Blood; 2003 Aug; 102(3):881-6. PubMed ID: 12676789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
    Du Z; Wang Z; Zhang W; Cai H; Tan WS
    Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution.
    Gammaitoni L; Bruno S; Sanavio F; Gunetti M; Kollet O; Cavalloni G; Falda M; Fagioli F; Lapidot T; Aglietta M; Piacibello W
    Exp Hematol; 2003 Mar; 31(3):261-70. PubMed ID: 12644024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.